ArticleEye (London, England)2022

Real-world cost-effectiveness of anti-VEGF monotherapy and combination therapy for the treatment of polypoidal choroidal vasculopathy.

Junxing Chay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.